JPRN-UMIN000005116已完成未知
Switching from Lopinavir/Ritonavir Plus Tenofovir and Emtricitabine (or Lamivudine) to Darunavir (Prezista) and Raltegravir to Evaluate Renal Function - SPARE Study
AIDS Clinical Center at National Center for Global Health and Medicine0 个研究点目标入组 54 人开始时间: 2011年2月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Cases applicable to any of the following will be excluded from this trial: 1) HBs antigen positive within 15 weeks to the enrollment (cases confirmed as HBs antibody positive can be enrolled without HBs antigen testing) 2) Malabsorption or gastrointestinal symptoms that affect absorption of the drugs, or dysphagia cases 3) Clinical data within 15 weeks before the start of the trial and of the closest date to the enrollment that are: a. GPT 2.5 times the highest of the normal range (grade 2) b. eGFR less than 60ml/min (Cockcroft-Gault formula) 4) Cases with opportunistic infections requiring treatment (primary and secondary preventive prophylaxis can be administrated during the study) 5) Cases during pregnancy or nursing period, or with a possibility for pregnancy 6) Using drugs that are prohibited to combine for drug interaction with the drugs of this trial 7) Other cases that are decided by the patient's physician as not suitable for the trial
研究者
相似试验
已完成
不适用
Efficacy and safety after switching from tenofovir disoproxil fumarate to tenofovir alafenamide containing antiretroviral therapy in virologically suppressed HIV-infected patientsHIV infectionJPRN-UMIN000038177Kyushu University Hospital Department of General internal medicine120
已完成
3 期
Switching to Tenofovir Alafenamide Fumarate or ABACavir in patients with Tenofovir Disoproxil Fumarate associated eGFR decline. A randomized clinical trial.AIDSHIV1002146010047438NL-OMON46033Erasmus MC, Universitair Medisch Centrum Rotterdam80
进行中（未招募）
1 期
Switching to tenofovir alafenamide fumarate or abacavir in patients with renal impairment due to tenofovir disoproxil fumarate.Renal safety of switching from TDF to TAF or ABC in patients with TDF-associated eGFR-decline.EUCTR2015-005045-31-NLErasmus MC
进行中（未招募）
1 期
Efficacy of Switching to Lopinavir/Ritonavir (Kaletra) in Improving Cognitive function in patients treated with Efavirenz (EFV) (SLICE Study)EUCTR2011-005581-37-GBThe Newcastle upon Tyne Hospitals NHS Foundation Trust16
已完成
4 期
Switching from efavirenz/tenofovir/emtricitabine (TDF/FTC/EFV) to abacavir/lamivudine/maraviroc (ABC/3TC/MVC) to assess antiretroviral activity in cerebrospinal fluidHuman immunodeficiency virus (HIV)Infections and InfestationsISRCTN08592155Institute of Biomedical Investigations of Bellvitge [Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)] (Spain)15